-
【GE CHENG News】Ceremonies for the 18th China (Wuxi) International Design Expo held in Wuxi
2025-05-07The 18th China (Wuxi) International Design Expo opened in Wuxi on September 9 during which the Golden Award winners were given the 24th WIPO-CNIPA Award for Chinese Outstanding Patented Invention & Industrial Design. Daren Tang, Director General of the World Intellectual Property Organization (WIPO) -
【GE CHENG News】Huawei’s new electric vehicle patent “the battery can be integrated into the body” is announced to improve battery life and safety
2025-05-07These days, Huawei has obtained another patented technology for electric vehicle batteries, called "Structure Battery and Electric Vehicles", and the patent has been published.The abstract shows that the patent is an integrated structure with a battery and vehicle body, including a body frame and a -
【GE CHENG News】Avanci announces 5G connected car license rate, with Huawei, Coolpad and other Chinese companies involved
2025-05-07On August 16, Avanci announced the launch of the 5G connected car project, which is to simplify the licensing process for next-generation connected cars to obtain cellular technology. Cellular Vehicle-to-Everything (C-V2X) allows a full range of connectivity and communications between vehicles and s -
【GE CHENG News】Hengrui Medicine's revenue in the first half of 2023 is 11.168 billion with a net profit 2.308 billion, a year-on-year increase of 9.19% and 8.91%
2025-05-07On the night of August 18, Hengrui Medicine released its performance report for the first half of 2023, which shows that Hengrui Medicine achieved an operating income of 11.168 billion yuan, a year-on-year increase of 9.19%; net profit attributable to shareholders of listed companies was 2.308 billi -
【GE CHENG News】Yabao Pharmaceutical plans to transfer the traditional Chinese medicine "Chaigui granules" owned by Shanxi University for 26 million yuan
2025-05-07Yabao Pharmaceutical announced on August 7 that the company signed a technology transfer agreement for new traditional Chinese medicine projects with Shanxi University on August 6, transferring the clinical trial approval documents, patent rights, and related technical information. of the Class 6.1